BioSpace News Archive

Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol

Strategic acquisition creates the healthcare industry’s only large-scale provider of governance, risk and compliance and human capital management software solutions

CVS Health Corporation announced operating results for the three months and year ended December 31, 2018.

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that it will host a conference call on Wednesday, February 27, 2019, at 4:30 p.m. ET to discuss its financial results for the quarter and full-year ended December 31, 2018,

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company” or “we”) today announced its fourth-quarter and full-year 2018 financial results.

Anthem and Carilion collaborate to increase access to high-quality healthcare

Verastem, Inc., a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, announced several key appointments to its management team.

The Walton Family Foundation released new research today that ranks micropolitan areas across the United States, creating a data-driven index to measure economic performance across America’s small towns across the Heartland and beyond.

Codiak BioSciences, Inc., a leading exosome therapeutics company, today announced the appointment of Andrea DiFabio as Chief Legal Officer. Ms. DiFabio will serve on the executive leadership team and report to Codiak’s president and CEO, Douglas E. Williams, Ph.D.

Unique collaboration pairs HLT’s data technology and artificial intelligence with PPD’s global expertise in clinical trials and real-world evidence generation